Patents
Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
12/2001
12/18/2001US6331554 Antipicornaviral compounds, compositions containing them, and methods for their use
12/18/2001US6331553 Inhibitors of nitric oxide synthase; treating cerebrovascular diseases
12/18/2001US6331543 Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use
12/18/2001US6331541 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
12/18/2001US6331537 Treating neurological disorders in animals
12/18/2001US6331507 Substituted aromatic thiocarboxylic acid amides and their use as herbicides
12/18/2001CA2213815C Pyrrolidinyl hydroxamic acid compounds and their production process
12/18/2001CA2208585C Benzamidoxime derivative, process for production thereof, and agrohorticultural bactericide
12/13/2001WO2001094304A1 Process for the production of sulfonic esters
12/13/2001WO2001049275A3 Methods and compositions for mitigating pain using nitrate esters
12/13/2001US20010051653 Method for improving disturbancies of activities of daily living after stroke
12/13/2001US20010051641 A medicine for preventive/treatment of disease caused by mitochondrial membrane depolarization because of elevation of intracellular calcium ion concentration; benzodiazepine receptor antagonist, e.g.,nefiracetam; antiischemic agents
12/12/2001EP1161415A2 N-cyanomethylamides as protease inhibitors
12/12/2001EP1161240A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
12/12/2001EP1161232A1 Hydroxy diphenyl urea sulfonamides as il-8 receptor antagonists
12/12/2001EP0765865B1 2-acylaminopropanol compound and medicinal composition
12/12/2001CN1326439A Phenyl-substituted cyclic enaminones
12/12/2001CN1325847A Compound with electron providing and receiving functional groups
12/11/2001US6329418 Substituted pyrrolidine hydroxamate metalloprotease inhibitors
12/11/2001US6329394 Medical use for tachykinin antagonists
12/11/2001US6329372 Phenylalanine derivatives
12/06/2001WO2001092241A1 Benzamide derivatives and their use as apob-100 and mtp inhibitors
12/06/2001WO2001092222A1 Preparation of 2-hydroxy-5-oxoproline and analogs thereof
12/06/2001WO2001092218A2 Polyamine analogues as therapeutic and diagnostic agents
12/06/2001WO2001092215A2 Superoxide-generating diazeniumdiolates, compositions comprising same, and methods for using same
12/06/2001US20010049449 Aromatic sulfonyl alpha-cycloamino hydroxamates and their use as MMP inhibitors
12/06/2001US20010049373 Substituted 4-phenoxy-6-aminopyrimidines
12/06/2001US20010049371 Reducing levels of tumor necrosis factor alpha; inhibition of undesireable levels of matrix metalloproteinases
12/06/2001US20010049367 Cyclic and bicyclic diamino histamine-3 receptor antagonists
12/06/2001CA2410935A1 Novel polyamine analogues as therapeutic and diagnostic agents
12/05/2001EP1158985A1 OMEGA-CARBOXY ARYL SUBSTITUTED DIPHENYL UREAS AS p38 KINASE INHIBITORS
12/05/2001EP1158980A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
12/05/2001CN1325385A Gastrin and cholecystokinin receptor ligands
12/05/2001CN1325380A Benzene derivatives and medical use thereof
12/05/2001CN1325377A New esters derived from substituted phenyl-cyclohexyl compounds
12/05/2001CN1325376A Novel compounds and medicinal use thereof
12/04/2001USH2007 Insecticidal N-heterocyclylalkyl-or N-[(polycyclyl)alkyl]-N′substituted piperazines
12/04/2001US6326393 Glycol and hydroxyphosphonate peptidomimetics as inhibitors of aspartyl proteases
11/2001
11/29/2001WO2001090097A2 Novel compounds having antiinflammatory activity: process for their preparation and pharmaceutical compositions containing them
11/29/2001WO2001090082A1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
11/29/2001WO2001090081A1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
11/29/2001WO2001090067A1 Tyrosine phosphatase inhibitors
11/29/2001WO2001090066A2 Method for obtaining pure n-vinyl pyrrolidone
11/29/2001WO2001055115A8 Substituted nicotinamides and analogs as activators of caspases and inducers of apoptosis and the use thereof
11/29/2001WO2001049674A3 Glycosidase inhibitors and preparation thereof
11/29/2001WO2001028996A3 Pyrrolidine derivatives, their preparation and their use as inhibitors of neuraminidases
11/29/2001WO2000059882A9 Anticancer calcium channel blockers
11/29/2001US20010047105 EP4 receptor selective agonists in the treatment of osteoporosis
11/29/2001US20010047031 Heterocyclic compounds useful as NMDA receptor selective subtype blockers
11/29/2001US20010046981 N-acyl-heterocycle-carboxyamides that are N-substituted with amidino-substituted rings; competitive inhibitors of thrombin; anticoagulants
11/29/2001US20010046953 Useful in laundry, automatic dishwashing and hard surface cleaning
11/29/2001DE10026233A1 Verfahren zur Gewinnung von reinem N-Vinylpyrrolidon A process for the recovery of pure N-vinylpyrrolidone
11/29/2001CA2412651A1 Novel compounds having antiinflammatory activity: process for their preparation and pharmaceutical compositions containing them
11/29/2001CA2410338A1 Tyrosine phosphatase inhibitors
11/28/2001EP1157997A1 Novel dipeptide compound and medicinal use thereof
11/28/2001EP1157984A2 Trypsin substrate and diagnostic device, and method of using same
11/28/2001EP1157021A1 Sulfamato hydroxamic acid metalloprotease inhibitor
11/28/2001EP1156807A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
11/28/2001EP1156803A1 LACTAM INHIBITORS OF FXa AND METHOD
11/28/2001EP0912089B1 Novel n-acyl sulphonamides, novel mixtures of herbicides and antidotes and their use
11/27/2001US6323345 Process for Cis-1-{2-[4-(6-methoxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenoxy]ethyl}pyrrolidine
11/27/2001US6323229 Compounds are useful psychotherapeutics and are potent agonists and/or antagonists of the serotonin 1a (5-ht 1a) and/or serotonin 1d (5-ht 1d) for treatment of hypertension, depression, generalized anxiety disorder
11/27/2001US6323227 Prodrugs
11/27/2001US6323223 Ccr-3 receptor antagonists, pharmaceutical compositions containing them, methods for their use and methods for preparing these compounds.
11/27/2001US6323207 Treatment or reduction of tissue damage due to ischaemia which comprises administering to a host suffering from ischaemia
11/27/2001US6323181 Antitumor agents
11/27/2001CA2018562C Process for the enzymatic cleavage of vinyl 2-aryl-propionates
11/22/2001WO2001087866A1 Cyclohexyl derivatives and their use as therapeutic agents
11/22/2001WO2001087838A1 Cyclohexane derivatives and their use as therapeutic agents
11/22/2001WO2001087830A2 Substituted thioacetamides
11/22/2001WO2001087299A1 Aralkyl ester soft drugs
11/22/2001WO2001087288A2 Method of treating vaginal dryness with nicotinic acetylcholine receptor agonists
11/22/2001US20010044544 Useful as high energy oxidizing agents in explosive and propellant formulations, and drugs for vasodilation
11/22/2001US20010044532 By reacting phosgene and lactam in the presence of a non-nucleophilic aliphatic tertiary amine, such as N,N-diisopropylethylamine; high purity, good yields
11/22/2001US20010044455 Method of treatment for decreasing mortality resulting from congestive heat failure
11/22/2001US20010044454 Thrombin receptor antagonists
11/22/2001US20010044452 Anticonvulsants
11/22/2001US20010044417 Compound containing a labile disulfide bond
11/22/2001US20010044404 Cleaning process and composition
11/22/2001US20010044061 Electrophotosensitive material
11/22/2001DE10022829A1 p-Aminophenol-Derivate und diese Verbindungen enthaltende Färbemittel p-aminophenol derivatives and compositions containing these compounds colorant
11/22/2001DE10022828A1 New 3-furyl-, 3-thienyl- and 3-pyrrolyl-aminophenol derivatives are useful in oxidative colorants for keratin fibers, especially hair
11/22/2001CA2410077A1 Cyclohexyl derivatives and their use as therapeutic agents
11/22/2001CA2409116A1 Substituted thioacetamides
11/22/2001CA2408849A1 Cyclohexane derivatives and their use as therapeutic agents
11/22/2001CA2407099A1 Aralkyl ester soft drugs
11/21/2001EP1156036A2 Compounds with electron donor and electron acceptor functionality
11/21/2001EP1155010A1 Acetamido acetonitrile derivatives as inhibitors of cathepsin l and/or cathepsin s
11/21/2001EP1154996A2 Aroyl aminoacyl pyrroles for use in the treatment of neuropathic pain
11/21/2001EP1154984A1 Inhibitors for uptake of serotonine, dopamine or norepinephrine
11/21/2001EP0914319B1 Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists
11/21/2001EP0831910B1 Epoxy-steroidal aldosterone antagonist and angiotensin ii antagonist combination therapy for treatment of congestive heart failure
11/21/2001CN1323314A Inhibitors of caspases
11/21/2001CN1323294A Cyclic ester or amide derivatives
11/21/2001CN1323293A The preparation of i(N)-substituted-hydroxycycloalkylamine derivatives
11/21/2001CN1323291A Diaminopropionic acid derivatives
11/21/2001CN1322718A Process for producing N.N'-carbonyl dilactan
11/21/2001CN1322714A 2-N-(N'-benzyl) prolyl-amino-diphenyl ketone producing process
11/21/2001CN1322712A Succinimide-acid compound and its derivative
11/21/2001CN1322526A Compound for treating female sexual dysfunction